Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00660816 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: erlotinib hydrochloride
DRUG: pemetrexed disodium
DRUG: docetaxel

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]